Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
Conclusions: Independent of a range of predictor variables, adalimumab was shown to be effective, while maintaining a high retention rate after 2 years in PsA patients.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Arthritis | Drugs & Pharmacology | Humira | Italy Health | Laboratory Medicine | Psoriatic Arthritis | Rheumatology | Study